<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font5" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font6" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font7" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font8" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font9" size="7" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font10" size="10" family="SymbolMT" color="#000000"/>
	<fontspec id="font11" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font12" size="8" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font13" size="8" family="GillSans" color="#000000"/>
<text top="41" left="55" width="92" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>BMC Nuclear Medicine</i></text>
<text top="41" left="147" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2007, </text>
<text top="41" left="174" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>7</b></text>
<text top="41" left="180" width="7" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:3</text>
<text top="41" left="373" width="181" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.biomedcentral.com/1471-2385/7/3</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t6" reading_order_no="174" segment_no="16" tag_type="text">Page 4 of 9</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="175" segment_no="17" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="216" left="55" width="36" height="10" font="font4" id="p1_t8" reading_order_no="36" segment_no="5" tag_type="title"><b>Results</b></text>
<text top="228" left="55" width="75" height="9" font="font5" id="p1_t9" reading_order_no="37" segment_no="7" tag_type="title"><i><b>Laboratory assays</b></i></text>
<text top="239" left="55" width="241" height="9" font="font6" id="p1_t10" reading_order_no="38" segment_no="9" tag_type="text">Different laboratory values monitored for this study are</text>
<text top="251" left="55" width="241" height="9" font="font6" id="p1_t11" reading_order_no="39" segment_no="9" tag_type="text">plotted with respect to the time categories for each of the</text>
<text top="263" left="55" width="241" height="9" font="font6" id="p1_t12" reading_order_no="40" segment_no="9" tag_type="text">20 study participants (F<a href="">igures 1 and 2). Table 2 s</a>umma-</text>
<text top="275" left="55" width="241" height="9" font="font6" id="p1_t13" reading_order_no="41" segment_no="9" tag_type="text">rizes the mean and standard deviation for each parameter</text>
<text top="286" left="55" width="241" height="9" font="font6" id="p1_t14" reading_order_no="42" segment_no="9" tag_type="text">over time. No statistically significant change was observed</text>
<text top="298" left="55" width="241" height="9" font="font6" id="p1_t15" reading_order_no="43" segment_no="9" tag_type="text">in sodium, potassium, chloride, glucose, creatinine, BUN,</text>
<text top="310" left="55" width="241" height="9" font="font6" id="p1_t16" reading_order_no="44" segment_no="9" tag_type="text">SGOT, SGPT, Alk Phos, total bilirubin, WBC, and platelet</text>
<text top="322" left="55" width="30" height="9" font="font6" id="p1_t17" reading_order_no="45" segment_no="9" tag_type="text">levels (</text>
<text top="322" left="86" width="7" height="9" font="font7" id="p1_t18" reading_order_no="46" segment_no="9" tag_type="text"><i>p </i></text>
<text top="322" left="93" width="203" height="9" font="font6" id="p1_t19" reading_order_no="47" segment_no="9" tag_type="text">&gt; 0.05). The mean for each of these parameters</text>
<text top="333" left="55" width="241" height="9" font="font6" id="p1_t20" reading_order_no="48" segment_no="9" tag_type="text">remained within normal limits over time (Table <a href="">2</a>). Albu-</text>
<text top="345" left="55" width="241" height="9" font="font6" id="p1_t21" reading_order_no="49" segment_no="9" tag_type="text">min, RBC, and hematocrit show a statistically significant</text>
<text top="357" left="55" width="241" height="9" font="font6" id="p1_t22" reading_order_no="50" segment_no="9" tag_type="text">decrease over time. Bonferroni analyses demonstrated</text>
<text top="369" left="55" width="241" height="9" font="font6" id="p1_t23" reading_order_no="51" segment_no="9" tag_type="text">that albumin decrease results mainly from an initial</text>
<text top="380" left="55" width="152" height="9" font="font6" id="p1_t24" reading_order_no="52" segment_no="9" tag_type="text">decrease of 11.5% between the pre-</text>
<text top="380" left="208" width="8" height="6" font="font8" id="p1_t25" reading_order_no="53" segment_no="9" tag_type="text">18</text>
<text top="380" left="215" width="81" height="9" font="font6" id="p1_t26" reading_order_no="54" segment_no="9" tag_type="text">F-FLT PET measure</text>
<text top="392" left="55" width="110" height="9" font="font6" id="p1_t27" reading_order_no="55" segment_no="9" tag_type="text">and the immediate post-</text>
<text top="392" left="165" width="8" height="6" font="font8" id="p1_t28" reading_order_no="56" segment_no="9" tag_type="text">18</text>
<text top="392" left="173" width="108" height="9" font="font6" id="p1_t29" reading_order_no="57" segment_no="9" tag_type="text">F-FLT PET blood draw (</text>
<text top="392" left="281" width="7" height="9" font="font7" id="p1_t30" reading_order_no="58" segment_no="9" tag_type="text"><i>p </i></text>
<text top="392" left="291" width="5" height="9" font="font6" id="p1_t31" reading_order_no="59" segment_no="9" tag_type="text">&lt;</text>
<text top="404" left="55" width="241" height="9" font="font6" id="p1_t32" reading_order_no="60" segment_no="9" tag_type="text">0.001). However, mean albumin values stayed within</text>
<text top="416" left="55" width="241" height="9" font="font6" id="p1_t33" reading_order_no="61" segment_no="9" tag_type="text">normal limits. For RBC and hematocrit (as well as for</text>
<text top="427" left="55" width="241" height="9" font="font6" id="p1_t34" reading_order_no="62" segment_no="9" tag_type="text">hemoglobin level, not plotted), significant decreases of</text>
<text top="439" left="55" width="210" height="9" font="font6" id="p1_t35" reading_order_no="63" segment_no="9" tag_type="text">respectively 4.7% and 4.5% occur between pre-</text>
<text top="439" left="265" width="8" height="6" font="font8" id="p1_t36" reading_order_no="64" segment_no="9" tag_type="text">18</text>
<text top="439" left="273" width="23" height="9" font="font6" id="p1_t37" reading_order_no="65" segment_no="9" tag_type="text">F-FLT</text>
<text top="451" left="55" width="87" height="9" font="font6" id="p1_t38" reading_order_no="66" segment_no="9" tag_type="text">and immediate post-</text>
<text top="450" left="142" width="8" height="6" font="font8" id="p1_t39" reading_order_no="67" segment_no="9" tag_type="text">18</text>
<text top="451" left="149" width="85" height="9" font="font6" id="p1_t40" reading_order_no="68" segment_no="9" tag_type="text">F-FLT blood drawn (</text>
<text top="451" left="235" width="7" height="9" font="font7" id="p1_t41" reading_order_no="69" segment_no="9" tag_type="text"><i>p </i></text>
<text top="451" left="241" width="55" height="9" font="font6" id="p1_t42" reading_order_no="70" segment_no="9" tag_type="text">&lt; 0.001), fol-</text>
<text top="463" left="55" width="241" height="9" font="font6" id="p1_t43" reading_order_no="71" segment_no="9" tag_type="text">lowed by decreases of respectively 8.3% and 8.4%</text>
<text top="474" left="55" width="152" height="9" font="font6" id="p1_t44" reading_order_no="72" segment_no="9" tag_type="text">between 5–24 hours and 1–7 days (</text>
<text top="474" left="207" width="7" height="9" font="font7" id="p1_t45" reading_order_no="73" segment_no="9" tag_type="text"><i>p </i></text>
<text top="474" left="215" width="82" height="9" font="font6" id="p1_t46" reading_order_no="74" segment_no="9" tag_type="text">&lt; 0.001). However,</text>
<text top="486" left="55" width="241" height="9" font="font6" id="p1_t47" reading_order_no="75" segment_no="9" tag_type="text">average levels for RBC remained within normal limits for</text>
<text top="498" left="55" width="241" height="9" font="font6" id="p1_t48" reading_order_no="76" segment_no="9" tag_type="text">the 1–7 days time point. Average values were just below</text>
<text top="510" left="55" width="241" height="9" font="font6" id="p1_t49" reading_order_no="77" segment_no="9" tag_type="text">normal for RBC after 1 week and for hematocrit for the</text>
<text top="521" left="55" width="241" height="9" font="font6" id="p1_t50" reading_order_no="78" segment_no="9" tag_type="text">first week and onwards. Because they are the only labora-</text>
<text top="533" left="55" width="241" height="9" font="font6" id="p1_t51" reading_order_no="79" segment_no="9" tag_type="text">tory parameters to exhibit a change, raw data, mean and</text>
<text top="545" left="55" width="241" height="9" font="font6" id="p1_t52" reading_order_no="80" segment_no="9" tag_type="text">standard deviations (SD) for albumin, RBC, and hemat-</text>
<text top="557" left="55" width="241" height="9" font="font6" id="p1_t53" reading_order_no="81" segment_no="9" tag_type="text">ocrit are also plotted for illustration (F<a href="">igures 1F</a>, <a href="">2A, 2C).</a></text>
<text top="568" left="55" width="241" height="9" font="font6" id="p1_t54" reading_order_no="82" segment_no="9" tag_type="text">The effect of surgical intervention on hemoglobin, hema-</text>
<text top="580" left="55" width="241" height="9" font="font6" id="p1_t55" reading_order_no="83" segment_no="9" tag_type="text">tocrit and RBC values was assessed by re-analyzing the</text>
<text top="592" left="55" width="241" height="9" font="font6" id="p1_t56" reading_order_no="84" segment_no="9" tag_type="text">data after excluding all post-surgical lab values from the</text>
<text top="604" left="55" width="241" height="9" font="font6" id="p1_t57" reading_order_no="85" segment_no="9" tag_type="text">original dataset. Bonferroni post-test performed on this</text>
<text top="615" left="55" width="241" height="9" font="font6" id="p1_t58" reading_order_no="86" segment_no="9" tag_type="text">reduced dataset still demonstrates the same significant</text>
<text top="627" left="55" width="241" height="9" font="font6" id="p1_t59" reading_order_no="87" segment_no="9" tag_type="text">decrease in hemoglobin, hematocrit and RBC values from</text>
<text top="639" left="55" width="17" height="9" font="font6" id="p1_t60" reading_order_no="88" segment_no="9" tag_type="text">pre-</text>
<text top="638" left="72" width="8" height="6" font="font8" id="p1_t61" reading_order_no="89" segment_no="9" tag_type="text">18</text>
<text top="639" left="79" width="116" height="9" font="font6" id="p1_t62" reading_order_no="90" segment_no="9" tag_type="text">F-FLT to immediately post-</text>
<text top="638" left="196" width="8" height="6" font="font8" id="p1_t63" reading_order_no="91" segment_no="9" tag_type="text">18</text>
<text top="639" left="203" width="93" height="9" font="font6" id="p1_t64" reading_order_no="92" segment_no="9" tag_type="text">F-FLT times but with-</text>
<text top="651" left="55" width="241" height="9" font="font6" id="p1_t65" reading_order_no="93" segment_no="9" tag_type="text">out subsequent lowering at later time points. Haptoglobin</text>
<text top="662" left="55" width="241" height="9" font="font6" id="p1_t66" reading_order_no="94" segment_no="9" tag_type="text">levels measured for the last 3 patients of the study did not</text>
<text top="674" left="55" width="140" height="9" font="font6" id="p1_t67" reading_order_no="95" segment_no="9" tag_type="text">reveal any evidence of hemolysis.</text>
<text top="698" left="55" width="241" height="9" font="font6" id="p1_t68" reading_order_no="96" segment_no="15" tag_type="text">No side effects including nausea, vomiting, dizziness, or</text>
<text top="709" left="55" width="241" height="9" font="font6" id="p1_t69" reading_order_no="97" segment_no="15" tag_type="text">headache were reported during 18F-FLT injection or dur-</text>
<text top="721" left="55" width="136" height="9" font="font6" id="p1_t70" reading_order_no="98" segment_no="15" tag_type="text">ing the following 2.0–2.5 hours.</text>
<text top="216" left="313" width="103" height="9" font="font5" id="p1_t71" reading_order_no="99" segment_no="6" tag_type="title"><i><b>Neurological evaluations</b></i></text>
<text top="228" left="313" width="241" height="9" font="font6" id="p1_t72" reading_order_no="100" segment_no="8" tag_type="text">No change was observed in the results of the neurological</text>
<text top="239" left="313" width="241" height="9" font="font6" id="p1_t73" reading_order_no="101" segment_no="8" tag_type="text">examinations performed on all patients before and imme-</text>
<text top="251" left="313" width="67" height="9" font="font6" id="p1_t74" reading_order_no="102" segment_no="8" tag_type="text">diately after the </text>
<text top="251" left="380" width="8" height="6" font="font8" id="p1_t75" reading_order_no="103" segment_no="8" tag_type="text">18</text>
<text top="251" left="388" width="166" height="9" font="font6" id="p1_t76" reading_order_no="104" segment_no="8" tag_type="text">F-FLT PET imaging sessions. A review of</text>
<text top="263" left="313" width="241" height="9" font="font6" id="p1_t77" reading_order_no="105" segment_no="8" tag_type="text">each subject's clinical record covering the 4 months fol-</text>
<text top="275" left="313" width="32" height="9" font="font6" id="p1_t78" reading_order_no="106" segment_no="8" tag_type="text">lowing </text>
<text top="274" left="344" width="8" height="6" font="font8" id="p1_t79" reading_order_no="107" segment_no="8" tag_type="text">18</text>
<text top="275" left="352" width="202" height="9" font="font6" id="p1_t80" reading_order_no="108" segment_no="8" tag_type="text">F-FLT PET imaging revealed no interval develop-</text>
<text top="286" left="313" width="241" height="9" font="font6" id="p1_t81" reading_order_no="109" segment_no="8" tag_type="text">ment of new neurological complaints, signs or symptoms</text>
<text top="298" left="313" width="241" height="9" font="font6" id="p1_t82" reading_order_no="110" segment_no="8" tag_type="text">by the study participants. In particular, no new peripheral</text>
<text top="310" left="313" width="213" height="9" font="font6" id="p1_t83" reading_order_no="111" segment_no="8" tag_type="text">neuropathy was reported in any of the 20 patients.</text>
<text top="334" left="313" width="82" height="9" font="font5" id="p1_t84" reading_order_no="112" segment_no="10" tag_type="title"><i><b>Calculation of AUC</b></i></text>
<text top="338" left="395" width="9" height="6" font="font9" id="p1_t85" reading_order_no="113" segment_no="10" tag_type="title"><i><b>12 </b></i></text>
<text top="334" left="404" width="131" height="9" font="font5" id="p1_t86" reading_order_no="114" segment_no="10" tag_type="title"><i><b>for a 5 mCi radiotracer dose of </b></i></text>
<text top="333" left="535" width="7" height="6" font="font9" id="p1_t87" reading_order_no="115" segment_no="10" tag_type="title"><i><b>18</b></i></text>
<text top="334" left="542" width="8" height="9" font="font5" id="p1_t88" reading_order_no="116" segment_no="10" tag_type="title"><i><b>F-</b></i></text>
<text top="345" left="313" width="16" height="9" font="font5" id="p1_t89" reading_order_no="117" segment_no="10" tag_type="title"><i><b>FLT</b></i></text>
<text top="357" left="313" width="241" height="9" font="font6" id="p1_t90" reading_order_no="118" segment_no="11" tag_type="text"><a href="">Figure 3 depic</a>ts 4 blood-derived TACs, each normalized</text>
<text top="369" left="313" width="91" height="9" font="font6" id="p1_t91" reading_order_no="119" segment_no="11" tag_type="text">to a standard 5 mCi </text>
<text top="368" left="404" width="8" height="6" font="font8" id="p1_t92" reading_order_no="120" segment_no="11" tag_type="text">18</text>
<text top="369" left="411" width="143" height="9" font="font6" id="p1_t93" reading_order_no="121" segment_no="11" tag_type="text">F-FLT injected dose. These decay-</text>
<text top="380" left="313" width="241" height="9" font="font6" id="p1_t94" reading_order_no="122" segment_no="11" tag_type="text">corrected curves illustrate the variability observed across</text>
<text top="392" left="313" width="131" height="9" font="font6" id="p1_t95" reading_order_no="123" segment_no="11" tag_type="text">patients in the elimination of </text>
<text top="392" left="444" width="8" height="6" font="font8" id="p1_t96" reading_order_no="124" segment_no="11" tag_type="text">18</text>
<text top="392" left="452" width="102" height="9" font="font6" id="p1_t97" reading_order_no="125" segment_no="11" tag_type="text">F-FLT from blood. They</text>
<text top="404" left="313" width="241" height="9" font="font6" id="p1_t98" reading_order_no="126" segment_no="11" tag_type="text">also illustrate the observation that at the conclusion of</text>
<text top="416" left="313" width="137" height="9" font="font6" id="p1_t99" reading_order_no="127" segment_no="11" tag_type="text">imaging the quantity of residual </text>
<text top="415" left="450" width="8" height="6" font="font8" id="p1_t100" reading_order_no="128" segment_no="11" tag_type="text">18</text>
<text top="416" left="458" width="96" height="9" font="font6" id="p1_t101" reading_order_no="129" segment_no="11" tag_type="text">F-FLT in the blood was</text>
<text top="427" left="313" width="185" height="9" font="font6" id="p1_t102" reading_order_no="130" segment_no="11" tag_type="text">small in all 20 patients. At 90 minutes post-</text>
<text top="427" left="498" width="8" height="6" font="font8" id="p1_t103" reading_order_no="131" segment_no="11" tag_type="text">18</text>
<text top="427" left="505" width="49" height="9" font="font6" id="p1_t104" reading_order_no="132" segment_no="11" tag_type="text">F-FLT injec-</text>
<text top="439" left="313" width="241" height="9" font="font6" id="p1_t105" reading_order_no="133" segment_no="11" tag_type="text">tion, the concentration of decay-corrected activity is on</text>
<text top="451" left="313" width="108" height="9" font="font6" id="p1_t106" reading_order_no="134" segment_no="11" tag_type="text">average 0.0454 ± 0.0272 </text>
<text top="448" left="421" width="6" height="12" font="font10" id="p1_t107" reading_order_no="135" segment_no="11" tag_type="text">μ</text>
<text top="451" left="426" width="128" height="9" font="font6" id="p1_t108" reading_order_no="136" segment_no="11" tag_type="text">Ci/mL. With a lowest accepta-</text>
<text top="463" left="313" width="124" height="9" font="font6" id="p1_t109" reading_order_no="137" segment_no="11" tag_type="text">ble specific activity of 0.1 Ci/</text>
<text top="460" left="437" width="6" height="12" font="font10" id="p1_t110" reading_order_no="138" segment_no="11" tag_type="text">μ</text>
<text top="463" left="443" width="111" height="9" font="font6" id="p1_t111" reading_order_no="139" segment_no="11" tag_type="text">mol, this corresponds to a</text>
<text top="474" left="313" width="241" height="9" font="font6" id="p1_t112" reading_order_no="140" segment_no="11" tag_type="text">concentration of FLT of 0.111 ± 0.0665 ng/mL if all radi-</text>
<text top="486" left="313" width="172" height="9" font="font6" id="p1_t113" reading_order_no="141" segment_no="11" tag_type="text">oactivity is assumed to be in the form of </text>
<text top="486" left="485" width="8" height="6" font="font8" id="p1_t114" reading_order_no="142" segment_no="11" tag_type="text">18</text>
<text top="486" left="493" width="62" height="9" font="font6" id="p1_t115" reading_order_no="143" segment_no="11" tag_type="text">F-FLT (FLT has</text>
<text top="498" left="313" width="241" height="9" font="font6" id="p1_t116" reading_order_no="144" segment_no="11" tag_type="text">a molecular weight of 244 g). Therefore, for the purpose</text>
<text top="510" left="313" width="241" height="9" font="font6" id="p1_t117" reading_order_no="145" segment_no="11" tag_type="text">of this study we are not considering the main labeled</text>
<text top="521" left="313" width="84" height="9" font="font6" id="p1_t118" reading_order_no="146" segment_no="11" tag_type="text">metabolite of FLT, </text>
<text top="521" left="397" width="8" height="6" font="font8" id="p1_t119" reading_order_no="147" segment_no="11" tag_type="text">18</text>
<text top="521" left="404" width="150" height="9" font="font6" id="p1_t120" reading_order_no="148" segment_no="11" tag_type="text">F-FLT-glucuronide, separately from</text>
<text top="533" left="313" width="8" height="6" font="font8" id="p1_t121" reading_order_no="149" segment_no="11" tag_type="text">18</text>
<text top="533" left="321" width="26" height="9" font="font6" id="p1_t122" reading_order_no="150" segment_no="11" tag_type="text">F-FLT.</text>
<text top="557" left="313" width="116" height="9" font="font6" id="p1_t123" reading_order_no="151" segment_no="12" tag_type="text">The imaging-derived AUC</text>
<text top="561" left="430" width="9" height="6" font="font8" id="p1_t124" reading_order_no="152" segment_no="12" tag_type="text">12 </text>
<text top="557" left="441" width="113" height="9" font="font6" id="p1_t125" reading_order_no="153" segment_no="12" tag_type="text">values range from 0.405</text>
<text top="568" left="313" width="241" height="9" font="font6" id="p1_t126" reading_order_no="154" segment_no="12" tag_type="text">ng*h/mL to 1.26 ng*h/mL with a mean of 0.770 ± 0.285</text>
<text top="580" left="313" width="233" height="9" font="font6" id="p1_t127" reading_order_no="155" segment_no="12" tag_type="text">ng*h/mL. The calculated blood sample-derived AUC</text>
<text top="585" left="546" width="8" height="6" font="font8" id="p1_t128" reading_order_no="156" segment_no="12" tag_type="text">12</text>
<text top="592" left="313" width="241" height="9" font="font6" id="p1_t129" reading_order_no="157" segment_no="12" tag_type="text">ranged from 0.232 ng*h/mL to 1.34 ng*h/mL with a</text>
<text top="604" left="313" width="241" height="9" font="font6" id="p1_t130" reading_order_no="158" segment_no="12" tag_type="text">mean of 0.802 ± 0.303 ng*h/mL. No significant difference</text>
<text top="615" left="313" width="48" height="9" font="font6" id="p1_t131" reading_order_no="159" segment_no="12" tag_type="text">in the AUC</text>
<text top="620" left="361" width="9" height="6" font="font8" id="p1_t132" reading_order_no="160" segment_no="12" tag_type="text">12 </text>
<text top="615" left="371" width="183" height="9" font="font6" id="p1_t133" reading_order_no="161" segment_no="12" tag_type="text">values obtained by the 2 different methods</text>
<text top="627" left="313" width="162" height="9" font="font6" id="p1_t134" reading_order_no="162" segment_no="12" tag_type="text">was found (Wilcoxon signed rank test, </text>
<text top="627" left="476" width="7" height="9" font="font7" id="p1_t135" reading_order_no="163" segment_no="12" tag_type="text"><i>p </i></text>
<text top="627" left="483" width="71" height="9" font="font6" id="p1_t136" reading_order_no="164" segment_no="12" tag_type="text"><a href="">= 0.66, Figure 4).</a></text>
<text top="651" left="313" width="52" height="10" font="font4" id="p1_t137" reading_order_no="165" segment_no="13" tag_type="title"><b>Discussion</b></text>
<text top="662" left="313" width="241" height="9" font="font6" id="p1_t138" reading_order_no="166" segment_no="14" tag_type="text">The purpose of this study was to evaluate the potential</text>
<text top="674" left="313" width="49" height="9" font="font6" id="p1_t139" reading_order_no="167" segment_no="14" tag_type="text">toxicity of </text>
<text top="674" left="362" width="8" height="6" font="font8" id="p1_t140" reading_order_no="168" segment_no="14" tag_type="text">18</text>
<text top="674" left="370" width="184" height="9" font="font6" id="p1_t141" reading_order_no="169" segment_no="14" tag_type="text">F-FLT when administered in a radiotracer</text>
<text top="686" left="313" width="241" height="9" font="font6" id="p1_t142" reading_order_no="170" segment_no="14" tag_type="text">dose for PET imaging. Such a study was made necessary</text>
<text top="698" left="313" width="241" height="9" font="font6" id="p1_t143" reading_order_no="171" segment_no="14" tag_type="text">because of previously reported toxicity in clinical trials</text>
<text top="709" left="313" width="241" height="9" font="font6" id="p1_t144" reading_order_no="172" segment_no="14" tag_type="text">employing therapeutic doses. In 1994, Flexner et al. pub-</text>
<text top="721" left="313" width="241" height="9" font="font6" id="p1_t145" reading_order_no="173" segment_no="14" tag_type="text">lished a concentration-control trial involving initially 14</text>
<text top="87" left="55" width="73" height="7" font="font11" id="p1_t146" reading_order_no="5" segment_no="2" tag_type="title"><b>Table 1: Time table</b></text>
<text top="105" left="202" width="6" height="7" font="font12" id="p1_t147" reading_order_no="6" segment_no="3" tag_type="table"><i><b>N</b></i></text>
<text top="105" left="286" width="37" height="7" font="font11" id="p1_t148" reading_order_no="7" segment_no="3" tag_type="table"><b>Minimum</b></text>
<text top="105" left="385" width="39" height="7" font="font11" id="p1_t149" reading_order_no="8" segment_no="3" tag_type="table"><b>Maximum</b></text>
<text top="105" left="483" width="42" height="7" font="font11" id="p1_t150" reading_order_no="9" segment_no="3" tag_type="table"><b>Mean ± SD</b></text>
<text top="127" left="119" width="32" height="7" font="font11" id="p1_t151" reading_order_no="10" segment_no="3" tag_type="table"><b>Pre-FLT</b></text>
<text top="127" left="201" width="8" height="7" font="font13" id="p1_t152" reading_order_no="11" segment_no="3" tag_type="table">20</text>
<text top="127" left="288" width="32" height="7" font="font13" id="p1_t153" reading_order_no="12" segment_no="3" tag_type="table">-3 h 43 m</text>
<text top="127" left="396" width="17" height="7" font="font13" id="p1_t154" reading_order_no="13" segment_no="3" tag_type="table">-37 d</text>
<text top="127" left="482" width="45" height="7" font="font13" id="p1_t155" reading_order_no="14" segment_no="3" tag_type="table">-5.4 d ± 8.7 d</text>
<text top="137" left="90" width="61" height="7" font="font11" id="p1_t156" reading_order_no="15" segment_no="3" tag_type="table"><b>Immediate &lt;5 h</b></text>
<text top="137" left="201" width="8" height="7" font="font13" id="p1_t157" reading_order_no="16" segment_no="3" tag_type="table">18</text>
<text top="137" left="290" width="30" height="7" font="font13" id="p1_t158" reading_order_no="17" segment_no="3" tag_type="table">1 h 24 m</text>
<text top="137" left="389" width="30" height="7" font="font13" id="p1_t159" reading_order_no="18" segment_no="3" tag_type="table">4 h 12 m</text>
<text top="137" left="480" width="47" height="7" font="font13" id="p1_t160" reading_order_no="19" segment_no="3" tag_type="table">2 h 20 ± 41 m</text>
<text top="148" left="102" width="48" height="7" font="font11" id="p1_t161" reading_order_no="20" segment_no="3" tag_type="table"><b>5 – 24 Hours</b></text>
<text top="148" left="201" width="8" height="7" font="font13" id="p1_t162" reading_order_no="21" segment_no="3" tag_type="table">18</text>
<text top="148" left="290" width="30" height="7" font="font13" id="p1_t163" reading_order_no="22" segment_no="3" tag_type="table">5 h 37 m</text>
<text top="148" left="387" width="34" height="7" font="font13" id="p1_t164" reading_order_no="23" segment_no="3" tag_type="table">21 h 24 m</text>
<text top="148" left="478" width="51" height="7" font="font13" id="p1_t165" reading_order_no="24" segment_no="3" tag_type="table">9 h 43 ± 5 h 42</text>
<text top="158" left="108" width="43" height="7" font="font11" id="p1_t166" reading_order_no="25" segment_no="3" tag_type="table"><b>First Week</b></text>
<text top="158" left="201" width="8" height="7" font="font13" id="p1_t167" reading_order_no="26" segment_no="3" tag_type="table">18</text>
<text top="158" left="296" width="17" height="7" font="font13" id="p1_t168" reading_order_no="27" segment_no="3" tag_type="table">1.1 d</text>
<text top="158" left="396" width="17" height="7" font="font13" id="p1_t169" reading_order_no="28" segment_no="3" tag_type="table">6.0 d</text>
<text top="158" left="483" width="42" height="7" font="font13" id="p1_t170" reading_order_no="29" segment_no="3" tag_type="table">4.4 d ± 1.1 d</text>
<text top="168" left="117" width="34" height="7" font="font11" id="p1_t171" reading_order_no="30" segment_no="3" tag_type="table"><b>&gt; 1 week</b></text>
<text top="168" left="201" width="8" height="7" font="font13" id="p1_t172" reading_order_no="31" segment_no="3" tag_type="table">19</text>
<text top="168" left="296" width="17" height="7" font="font13" id="p1_t173" reading_order_no="32" segment_no="3" tag_type="table">7.4 d</text>
<text top="168" left="392" width="25" height="7" font="font13" id="p1_t174" reading_order_no="33" segment_no="3" tag_type="table">155.8 d</text>
<text top="168" left="479" width="51" height="7" font="font13" id="p1_t175" reading_order_no="34" segment_no="3" tag_type="table">29.3 d ± 39.8 d</text>
<text top="190" left="59" width="111" height="7" font="font13" id="p1_t176" reading_order_no="35" segment_no="4" tag_type="text">m = minutes, h = hours, d = days</text>
</page>
</pdf2xml>
